Plans for Apple’s 2023 iPhones and Mac devices are reportedly underway. The tech giant is said to be working on making these the first hardware products with chips produced with Taiwan Semiconductor Manufacturing Company’s (TSMC) upgraded 3nm process.
Apple plans to make the A17 Bionic and M3 chips the first processors in the market that uses TSMC’s N3E node, Nikkei Asia reports. The iPhone maker’s leading chip supplier announced at its tech symposium in July that it will expand its 3nm chip making tech following the release of the N3 node. N3E will be the second entry in its 3nm-class node roadmap, and it is expected to deliver performance boosts while lowering power consumption.
The race to produce the first 3nm chips this year was won by Samsung Electronics after the company started the initial production of its 3nm process in late June. TSMC’s production using its N3 node reportedly followed after a little more than a month. This means devices powered by the first 3nm chips could enter the market by next year. For the processors of the 2023 iPhones and Macs, though, Apple is reportedly eyeing N3’s successor.
TSMC announced at its tech symposium last July that it will expand its 3nm chip making process with four upcoming nodes following the N3. The N3E chip tech, which is reportedly planned for the A17 and M3 chips, is the second node in the roadmap and could enter high volume production by mid-2023.
Considering Apple’s new strategy for the iPhone series, the A17 Bionic chip produced with TSMC’s N3E node will likely be exclusive to the iPhone 15 Pro models. iPhone 14 Pro and iPhone 14 Pro Max were the only devices Apple launched with the A16 chip this month. The company will keep using the A15 chip for the iPhone 14 and iPhone 14 Plus.
The same report noted that Intel, like Apple, also plans to be one of the first companies to adopt TSMC’s 3nm chip tech. Nikkei Asia’s sources, however, claimed that Intel postponed its orders for this year or early 2023 to sometime in 2024.
Photo by Anthony Choren on Unsplash


Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Google Cloud and Liberty Global Forge Strategic AI Partnership to Transform European Telecom Services
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 



